Zou D, Yin Z, Yi S, Wang G, Guo Y, Xiao X
Nat Immunol. 2024; 25(1):66-76.
PMID: 38168955
PMC: 11064861.
DOI: 10.1038/s41590-023-01682-z.
Horwitz J, Bin S, Fairchild R, Keslar K, Yi Z, Zhang W
JCI Insight. 2022; 7(10).
PMID: 35389892
PMC: 9220923.
DOI: 10.1172/jci.insight.158856.
Wang Y, Xiao X, Kong G, Wen M, Wang G, Ghobrial R
Am J Transplant. 2021; 22(2):414-426.
PMID: 34599765
PMC: 8813885.
DOI: 10.1111/ajt.16861.
Koyama M, Hill G
Front Immunol. 2021; 12:715893.
PMID: 34594330
PMC: 8476754.
DOI: 10.3389/fimmu.2021.715893.
Si Y, Tian Q, Zhao F, Kelly S, Shores L, Camacho D
Sci Adv. 2020; 6(32):eaba0995.
PMID: 32821819
PMC: 7413739.
DOI: 10.1126/sciadv.aba0995.
Ectromelia-encoded virulence factor C15 specifically inhibits antigen presentation to CD4+ T cells post peptide loading.
Forsyth K, Roy N, Peauroi E, DeHaven B, Wold E, Hersperger A
PLoS Pathog. 2020; 16(8):e1008685.
PMID: 32745153
PMC: 7425992.
DOI: 10.1371/journal.ppat.1008685.
Single-cell transcriptomics of alloreactive CD4+ T cells over time reveals divergent fates during gut graft-versus-host disease.
Engel J, Lee H, Williams C, Kuns R, Olver S, Lansink L
JCI Insight. 2020; 5(13).
PMID: 32484791
PMC: 7406307.
DOI: 10.1172/jci.insight.137990.
MHC-II alleles shape the CDR3 repertoires of conventional and regulatory naïve CD4 T cells.
Logunova N, Kriukova V, Shelyakin P, Egorov E, Pereverzeva A, Bozhanova N
Proc Natl Acad Sci U S A. 2020; 117(24):13659-13669.
PMID: 32482872
PMC: 7306996.
DOI: 10.1073/pnas.2003170117.
The lymph node stromal laminin α5 shapes alloimmunity.
Li L, Shirkey M, Zhang T, Xiong Y, Piao W, Saxena V
J Clin Invest. 2020; 130(5):2602-2619.
PMID: 32017712
PMC: 7190966.
DOI: 10.1172/JCI135099.
VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance.
ElTanbouly M, Zhao Y, Nowak E, Li J, Schaafsma E, Le Mercier I
Science. 2020; 367(6475).
PMID: 31949051
PMC: 7391053.
DOI: 10.1126/science.aay0524.
Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD.
Piper C, Zhou V, Komorowski R, Szabo A, Vincent B, Serody J
Blood. 2019; 135(8):568-581.
PMID: 31880771
PMC: 7033370.
DOI: 10.1182/blood.2019001696.
Differential Regulation of T-cell Immunity and Tolerance by Stromal Laminin Expressed in the Lymph Node.
Simon T, Li L, Wagner C, Zhang T, Saxena V, Brinkman C
Transplantation. 2019; 103(10):2075-2089.
PMID: 31343575
PMC: 6768765.
DOI: 10.1097/TP.0000000000002774.
Costimulation Induces CD4 T Cell Antitumor Immunity via an Innate-like Mechanism.
Morales Del Valle C, Maxwell J, Xu M, Menoret A, Mittal P, Tsurutani N
Cell Rep. 2019; 27(5):1434-1445.e3.
PMID: 31042471
PMC: 6508096.
DOI: 10.1016/j.celrep.2019.04.016.
Chrysalis: A New Method for High-Throughput Histo-Cytometry Analysis of Images and Movies.
Kotov D, Pengo T, Mitchell J, Gastinger M, Jenkins M
J Immunol. 2018; 202(1):300-308.
PMID: 30510065
PMC: 6310099.
DOI: 10.4049/jimmunol.1801202.
Gut microbiota-dependent modulation of innate immunity and lymph node remodeling affects cardiac allograft outcomes.
Bromberg J, Hittle L, Xiong Y, Saxena V, Smyth E, Li L
JCI Insight. 2018; 3(19).
PMID: 30282817
PMC: 6237453.
DOI: 10.1172/jci.insight.121045.
Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro.
Gee M, Sibener L, Birnbaum M, Jude K, Yang X, Fernandes R
Proc Natl Acad Sci U S A. 2018; 115(31):E7369-E7378.
PMID: 30021852
PMC: 6077720.
DOI: 10.1073/pnas.1802746115.
An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T Cells.
Mittal P, Abblett R, Ryan J, Hagymasi A, Agyekum-Yamoah A, Svedova J
J Immunol. 2018; 200(4):1513-1526.
PMID: 29305435
PMC: 5809300.
DOI: 10.4049/jimmunol.1701039.
Th17 plasticity and transition toward a pathogenic cytokine signature are regulated by cyclosporine after allogeneic SCT.
Gartlan K, Varelias A, Koyama M, Robb R, Markey K, Chang K
Blood Adv. 2018; 1(6):341-351.
PMID: 29296949
PMC: 5738990.
DOI: 10.1182/bloodadvances.2016002980.
TLR-Induced Murine Dendritic Cell (DC) Activation Requires DC-Intrinsic Complement.
Sheen J, Strainic M, Liu J, Zhang W, Yi Z, Medof M
J Immunol. 2017; 199(1):278-291.
PMID: 28539427
PMC: 5609833.
DOI: 10.4049/jimmunol.1700339.
Optimal CD4 T cell priming after LPS-based adjuvanticity with CD134 costimulation relies on CXCL9 production.
Shinde P, Liu W, Menoret A, Luster A, Vella A
J Leukoc Biol. 2017; 102(1):57-69.
PMID: 28432083
PMC: 5470836.
DOI: 10.1189/jlb.1A0616-261RR.